Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

Study ID
NCT01659502

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of TL-118 alone or in combination with pancreatic cancer chemotherapy.

More informations

Trial Starting Date

Dec 31,2013

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit